Document is current
Any future updates will be listed below
-
Authors
Heilmeier, Ursula https://orcid.org/0000-0003-0664-3413
Burghardt, Andrew J.
Tse, Justin J.
Kapoor, Puneet
Stok, Kathryn S.
Manske, Sarah
Voll, Reinhard E.
Schett, Georg
Finzel, Stephanie
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (FOR2886 PANDORA)
Deutsche Forschungsgemeinschaft (CRC1181 Checkpoints for Resolution of Inflammation)
European Research Council (ERC Synergy 4D Nanoscope)
European Calcified Tissue Society (ECTS Academy Personal Research Grant)
The Arthritis Society (STAR-18-0189)
Universitätsklinikum Freiburg
- License Information
-
More Information
Article History
Received: 6 May 2022
Accepted: 25 November 2022
First Online: 4 February 2023
Declarations
:
: AJ. Burghardt has served as a consultant for Ultragenyx Pharmaceutical Inc. and as a consultant to Mereo BioPharma Group PLC and received research support from Ultragenyx.
: Approval No. 4190 granted by the IRB of the University Clinic of Erlangen; Approval REB19-0387 granted by the University of Calgary’s Conjoint Health Research Ethics Board.
: No animals were harmed in this study.
: Available.
: Available and included in general consent that all participants signed prior to participation.
